Home › Steatotic Liver Disease › Washington
Pag-aaral pangklinika para sa Steatotic Liver Disease sa Washington
7 pag-aaral para sa Steatotic Liver Disease ang naghahanap ng mga kalahok sa mga site sa Washington.
Mga Lungsod sa Washington
Opisyal na teksto ng pag-aaral (English)
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
- Washington Gastroenterology - Bellevue, Bellevue
- UW Medicine Diabetes Institute, Seattle
- Washington Gastroenterology - Tacoma, Tacoma
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07165028A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
- Akero Clinical Study Site, Seattle
Nagre-recruitPhase 3
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Set 21, 2026 · NCT06528314A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
- GSK Investigational Site, Seattle
Nagre-recruitPhase 3
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 17, 2026 · NCT07221188A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- 89bio Clinical Study Site, Bellevue
- 89bio Clinical Study Site, Seattle
- 89bio Clinical Study Site, Seattle
- at 1 pa
Nagre-recruitPhase 3
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06318169A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- 89bio Clinical Study Site, Bellevue
- 89bio Clinical Study Site, Seattle
- 89bio Clinical Study Site, Seattle
- at 1 pa
Nagre-recruitPhase 3
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06419374A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
- GSK Investigational Site, Seattle
Nagre-recruitPhase 3
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Hul 27, 2026 · NCT07221227Development of a Quantifiable Ultrasound Biomarker for Hepatic Steatosis
- University of Washington, Seattle
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Dis 8, 2025 · NCT07270601Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.